Gene or Genome – Page 15

AstraZeneca, Imfinzi, Lynparza, endometrial cancer, EU approval, combination therapy, immunotherapy, PARP inhibitor, mismatch repair proficient, mismatch repair deficient

Galderma’s IL-31 Blocker Nemluvio Gains FDA Approval for Prurigo Nodularis

9 months ago talkbio0Tagged Approved, Blocker, Galderma, IL31 gene, Nemluvio, nodularis, Prurigo, United States Food and Drug Administration

Galderma, Nemluvio, IL-31 blocker, FDA approval, prurigo nodularis, therapeutic dermatology

Novartis Fails to Block MSN’s Entresto Generic Launch

9 months ago talkbio0Tagged Approved, Entresto, infringement, Legal patent, MSN gene, Novartis, United States Food and Drug Administration

Novartis, Entresto, MSN Pharmaceuticals, generic drugs, patent infringement, FDA approval

Galderma’s Nemluvio Receives FDA Approval for Prurigo Nodularis Treatment

9 months ago talkbio0Tagged Approved, chronic skin condition, Galderma, IL31 gene, Inhibitor, Nemluvio, Prurigo nodularis, Pruritus, United States Food and Drug Administration

Nemluvio, Galderma, FDA Approval, Prurigo Nodularis, IL-31 Inhibitor, Chronic Skin Condition, Itch Treatment

FDA Approves ARS’s Epinephrine Nasal Spray for Emergency Allergic Reactions

9 months ago talkbio0Tagged anaphylaxis, Approved, epinephrine, Epipen, Nasal Spray, needle-free alternative, SLURP1 gene, United States Food and Drug Administration

FDA approval, epinephrine nasal spray, ARS Pharmaceuticals, anaphylaxis treatment, needle-free alternative, EpiPen

FDA Criticizes Bristol Myers Squibb for Misleading Efficacy Claims on Krazati Website

9 months ago talkbio0Tagged Cancer Therapeutic Procedure, Claims, Effectiveness, K-ras Oncogene, KRAZATI, Myers, Non-Small Cell Lung Carcinoma, non-small-cell lung cancer, squibb, United States Food and Drug Administration

Bristol Myers Squibb, FDA, Krazati, misleading efficacy claims, non-small-cell lung cancer, NSCLC, KRAS G12C-mutated, cancer treatment